Explore the Performance of IntelliCap.

Summary

This is an open-label, randomised, 4-way crossover study in twelve healthy male volunteers. The study will characterise the performance of IntelliCap® by evaluating the plasma concentration and pharmacokinetic profile of a probe drug (IMP; metoprolol) released from IntelliCap® with three different release profiles and the plasma concentration and pharmacokinetic profile of the same probe drug after a single dose of an oral solution.

Timeline

Start

2014-01

Primary completion

2014-03

Completion

2014-03

Drugs

Indications

No indication recorded.